Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Corticosteroids for Radiation-induced Brain Necrosis in NPC
NCT01621880Phase 2Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2012
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bevacizumab in radiation necrosis (RN) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Number of Participants With a Treatment Response at 2 months. Started Jun 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
radiation necrosis (RN)
Beyond the preview
Go deeper on NCT01621880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621880.